urea has been researched along with syringolin a in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (25.00) | 29.6817 |
2010's | 6 (75.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bachmann, AS; Clerc, J; Dudler, R; Groll, M; Huber, R; Illich, DJ; Kaiser, M; Schellenberg, B | 1 |
Imker, HJ; Walsh, CT; Wuest, WM | 1 |
Biswas, G; Ibarra-Rivera, TR; Pirrung, MC | 1 |
Agarwal, P; Anshu, A; Ibarra-Rivera, TR; Pirrung, MC; Schönthal, AH; Thomas, S | 1 |
Kaiser, M; Krahn, D; Walsh, CT; Wuest, WM | 1 |
Kaiser, M; Krahn, D; Ottmann, C | 1 |
Bachmann, AS; Ibarra-Rivera, TR; Opoku-Ansah, J; Pirrung, MC | 1 |
Bian, X; Huang, F; Müller, R; Stewart, FA; Xia, L; Zhang, Y | 1 |
1 review(s) available for urea and syringolin a
Article | Year |
---|---|
The chemistry and biology of syringolins, glidobactins and cepafungins (syrbactins).
Topics: Biological Products; Humans; Molecular Structure; Peptides, Cyclic; Proteasome Inhibitors; Urea | 2011 |
7 other study(ies) available for urea and syringolin a
Article | Year |
---|---|
Synthetic and structural studies on syringolin A and B reveal critical determinants of selectivity and potency of proteasome inhibition.
Topics: Humans; Kinetics; Lipids; Peptides, Cyclic; Proteasome Inhibitors; Substrate Specificity; Urea; X-Rays | 2009 |
SylC catalyzes ureido-bond formation during biosynthesis of the proteasome inhibitor syringolin A.
Topics: Amino Acids; Catalysis; Peptides, Cyclic; Proteasome Inhibitors; Urea | 2009 |
Total synthesis of syringolin A and B.
Topics: Molecular Conformation; Peptides, Cyclic; Protease Inhibitors; Proteasome Inhibitors; Stereoisomerism; Urea | 2010 |
Novel proteasome-inhibitory syrbactin analogs inducing endoplasmic reticulum stress and apoptosis in hematological tumor cell lines.
Topics: Antineoplastic Agents; Apoptosis; Cell Culture Techniques; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Endoplasmic Reticulum; Hematologic Neoplasms; Humans; Immunoblotting; Molecular Structure; Oxidative Stress; Peptides, Cyclic; Proteasome Inhibitors; Urea | 2011 |
Enzymatic timing and tailoring of macrolactamization in syringolin biosynthesis.
Topics: Molecular Structure; Peptides, Cyclic; Stereoisomerism; Thiolester Hydrolases; Urea | 2011 |
Syringolin B-inspired proteasome inhibitor analogue TIR-203 exhibits enhanced biological activity in multiple myeloma and neuroblastoma.
Topics: Antineoplastic Agents; Boronic Acids; Bortezomib; Cell Line, Tumor; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Humans; Multiple Myeloma; Neuroblastoma; Peptides, Cyclic; Proteasome Inhibitors; Pyrazines; Urea | 2012 |
Direct cloning, genetic engineering, and heterologous expression of the syringolin biosynthetic gene cluster in E. coli through Red/ET recombineering.
Topics: Biosynthetic Pathways; Cloning, Molecular; Escherichia coli; Genetic Engineering; Multigene Family; Peptides, Cyclic; Pseudomonas syringae; Urea | 2012 |